Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods

Stefania Ordanini, Norbert Varga, Vanessa Porkolab, Michel Thépaut, Laura Belvisi, Andrea Bertaglia, Alessandro Palmioli, Angela Berzi, Daria Trabattoni, Mario Clerici, Franck Fieschi and Anna Bernardi

Chem. Commun., 2015, 51, 3816
DOI: 10.1039/C4CC09709B

Second generation of fucose-based DC-SIGN ligands : affinity improvement and specificity versus Langerin

Manuel Andreini, Daniela Doknic, Ieva Sutkeviciute, José J. Reina, Janxin Duan, Eric Chabrol, Michel Thepaut, Elisabetta Moroni, Fabio Doro, Laura Belvisi, Joerg Weiser, Javier Rojo, Franck Fieschi and Anna Bernardi

Org. Biomol. Chem., 2011, 9, 5778
DOI: 10.1039/c1ob05573a

Glycopolymers with secondary binding motifs mimic glycan branching and display bacterial lectin selectivity in addition to affinity

M. W. Jones, L. Otten, S.-J. Richards, R. Lowery, D. J. Phillips, D. M. Haddleton and M. I. Gibson

Chem. Sci., 2014, 5, 1611
DOI: 10.1039/C3SC52982G

Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN

Jonathan Cramer

RSC Med. Chem., 2021, 12, 1985
DOI: 10.1039/D1MD00238D

Crafting precise multivalent architectures

Paul M. Levine, Tom P. Carberry, Justin M. Holub and Kent Kirshenbaum

Med. Chem. Commun., 2013, 4, 493
DOI: 10.1039/C2MD20338C

Quinoxalinoneinhibitors of the lectin DC-SIGN

Shane L. Mangold, Lynne R. Prost and Laura L. Kiessling

Chem. Sci., 2012, 3, 772
DOI: 10.1039/C2SC00767C

Polymeric mannosides prevent DC-SIGN-mediated cell-infection by cytomegalovirus

S. Brument, C. Cheneau, Y. Brissonnet, D. Deniaud, F. Halary and S. G. Gouin

Org. Biomol. Chem., 2017, 15, 7660
DOI: 10.1039/C7OB01569K

Glycomimetics for the inhibition and modulation of lectins

Steffen Leusmann, Petra Ménová, Elena Shanin, Alexander Titz and Christoph Rademacher

Chem. Soc. Rev., 2023, 52, 3663
DOI: 10.1039/D2CS00954D

Stereoselective innovative synthesis and biological evaluation of new real carba analogues of minimal epitope Manα(1,2)Man as DC-SIGN inhibitors

Vittorio Bordoni, Vanessa Porkolab, Sara Sattin, Michel Thépaut, Ileana Frau, Lucilla Favero, Paolo Crotti, Anna Bernardi, Franck Fieschi and Valeria Di Bussolo

RSC Adv., 2016, 6, 89578
DOI: 10.1039/C6RA20401E

Glycopolymer probes of signal transduction

Laura L. Kiessling and Joseph C. Grim

Chem. Soc. Rev., 2013, 42, 4476
DOI: 10.1039/c3cs60097a

Monovalent mannose-based DC-SIGN antagonists: Targeting the hydrophobic groove of the receptor

Tihomir Tomašić, David Hajšek, Urban Švajger, Jernej Luzar, Nataša Obermajer, Isabelle Petit-Haertlein, Franck Fieschi and Marko Anderluh

European Journal of Medicinal Chemistry, 2014, 75, 308
DOI: 10.1016/j.ejmech.2014.01.047

Polymeric Anti‐HIV Therapeutics

Maarten Danial and Harm‐Anton Klok

Macromolecular Bioscience, 2015, 15, 9
DOI: 10.1002/mabi.201400298

A Remote Secondary Binding Pocket Promotes Heteromultivalent Targeting of DC-SIGN

Robert Wawrzinek, Eike-Christian Wamhoff, Jonathan Lefebre, Mareike Rentzsch, Gunnar Bachem, Gary Domeniconi, Jessica Schulze, Felix F. Fuchsberger, Hengxi Zhang, Carlos Modenutti, Lennart Schnirch, Marcelo A. Marti, Oliver Schwardt, Maria Bräutigam, Mónica Guberman, Dirk Hauck, Peter H. Seeberger, Oliver Seitz, Alexander Titz, Beat Ernst and Christoph Rademacher

J. Am. Chem. Soc., 2021, 143, 18977
DOI: 10.1021/jacs.1c07235

19F NMR-Guided Design of Glycomimetic Langerin Ligands

Eike-Christian Wamhoff, Jonas Hanske, Lennart Schnirch, Jonas Aretz, Maurice Grube, Daniel Varón Silva and Christoph Rademacher

ACS Chem. Biol., 2016, 11, 2407
DOI: 10.1021/acschembio.6b00561

Glycomimetics versus Multivalent Glycoconjugates for the Design of High Affinity Lectin Ligands

Samy Cecioni, Anne Imberty and Sébastien Vidal

Chem. Rev., 2015, 115, 525
DOI: 10.1021/cr500303t

New branched amino acids for high affinity dendrimeric DC-SIGN ligands

Laurent Cattiaux, Vanessa Porkolab, Franck Fieschi and Jean-Maurice Mallet

Bioorganic & Medicinal Chemistry, 2018, 26, 1006
DOI: 10.1016/j.bmc.2017.12.036

Fucosyl glycosides for DC-SIGN targeting: Fucosylation strategies, synthesis and binding studies of model compounds

Rohit Chavan, Jonathan Lefèbre, Kateřina Jochová, Hana Dvořáková, Christoph Rademacher and Petra Ménová

Bioorganic & Medicinal Chemistry, 2025, 123, 118164
DOI: 10.1016/j.bmc.2025.118164

Lewis‐X‐Containing Triterpenoid Saponins Inhibit DC‐SIGN‐ and L‐SIGN‐Mediated Transfer of HIV‐1 Infection

Oscar Javier Gamboa Marin, Kurtis Ng, Nitish Verma, Assi Gérard Flavien Yapi, Ralph Pantophlet and Charles Gauthier

Chemistry A European J, 2025, 31
DOI: 10.1002/chem.202500993

Glycomimetic Building Blocks: A Divergent Synthesis of Epimers of Shikimic Acid

Joseph C. Grim, Kathleen C. A. Garber and Laura L. Kiessling

Org. Lett., 2011, 13, 3790
DOI: 10.1021/ol201252x

Nonhydrolyzable C-disaccharides, a new class of DC-SIGN ligands

Benedetta Bertolotti, Beáta Oroszová, Ieva Sutkeviciute, Ladislav Kniežo, Franck Fieschi, Kamil Parkan, Zuzana Lovyová, Martina Kašáková and Jitka Moravcová

Carbohydrate Research, 2016, 435, 7
DOI: 10.1016/j.carres.2016.09.005

Cellular Uptake of Gold Nanoparticles Bearing HIV gp120 Oligomannosides

Blanca Arnáiz, Olga Martínez-Ávila, Juan M. Falcon-Perez and Soledad Penadés

Bioconjugate Chem., 2012, 23, 814
DOI: 10.1021/bc200663r

Non‐Carbohydrate Glycomimetics as Inhibitors of Calcium(II)‐Binding Lectins

Sakonwan Kuhaudomlarp, Eike Siebs, Elena Shanina, Jérémie Topin, Ines Joachim, Priscila da Silva Figueiredo Celestino Gomes, Annabelle Varrot, Didier Rognan, Christoph Rademacher, Anne Imberty and Alexander Titz

Angew Chem Int Ed, 2021, 60, 8104
DOI: 10.1002/anie.202013217

Identifikation sekundärer Bindestellen auf DC‐SIGN mithilfe eines Fragment‐Screenings

Jonas Aretz, Hannes Baukmann, Elena Shanina, Jonas Hanske, Robert Wawrzinek, Viktor A. Zapol'skii, Peter H. Seeberger, Dieter E. Kaufmann and Christoph Rademacher

Angewandte Chemie, 2017, 129, 7398
DOI: 10.1002/ange.201701943

Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists

Nataša Obermajer, Sara Sattin, Cinzia Colombo, Michela Bruno, Urban Švajger, Marko Anderluh and Anna Bernardi

Mol Divers, 2011, 15, 347
DOI: 10.1007/s11030-010-9285-y

Chemoenzymatic Synthesis of Complex N‐Glycans of the Parasite S. mansoni to Examine the Importance of Epitope Presentation on DC‐SIGN recognition

Apoorva D. Srivastava, Luca Unione, Mehman Bunyatov, Ivan A. Gagarinov, Sandra Delgado, Nicola G. A. Abrescia, Ana Ardá and Geert‐Jan Boons

Angew Chem Int Ed, 2021, 60, 19287
DOI: 10.1002/anie.202105647

Antigen structure affects cellular routing through DC-SIGN

Cassie M. Jarvis, Daniel B. Zwick, Joseph C. Grim, Mohammad Murshid Alam, Lynne R. Prost, Jaye C. Gardiner, Soyeong Park, Laraine L. Zimdars, Nathan M. Sherer and Laura L. Kiessling

Proc. Natl. Acad. Sci. U.S.A., 2019, 116, 14862
DOI: 10.1073/pnas.1820165116

Genetically-encoded fragment-based discovery of glycopeptide ligands for DC-SIGN

Simon Ng, Nicholas James Bennett, Jessica Schulze, Nan Gao, Christoph Rademacher and Ratmir Derda

Bioorganic & Medicinal Chemistry, 2018, 26, 5368
DOI: 10.1016/j.bmc.2018.08.036

Noncarbohydrate Glycomimetics and Glycoprotein Surrogates as DC-SIGN Antagonists and Agonists

Lynne R. Prost, Joseph C. Grim, Marco Tonelli and Laura L. Kiessling

ACS Chem. Biol., 2012, 7, 1603
DOI: 10.1021/cb300260p

Synthetic Agonists of Nod-Like, Rig-I-Like, and C-Type Lectin Receptors for Probing the Inflammatory Immune Response

Amy E Nielsen, Joseph D Hantho and Rock J Mancini

Future Med. Chem., 2017, 9, 1345
DOI: 10.4155/fmc-2017-0101

Selective Targeting of Dendritic Cell‐Specific Intercellular Adhesion Molecule‐3‐Grabbing Nonintegrin (DC‐SIGN) with Mannose‐Based Glycomimetics: Synthesis and Interaction Studies of Bis(benzylamide) Derivatives of a Pseudomannobioside

Norbert Varga, Ieva Sutkeviciute, Cinzia Guzzi, John McGeagh, Isabelle Petit‐Haertlein, Serena Gugliotta, Jörg Weiser, Jesús Angulo, Franck Fieschi and Anna Bernardi

Chemistry A European J, 2013, 19, 4786
DOI: 10.1002/chem.201202764

A C2-Symmetric Chiral Pool-Based Flexible Strategy: Synthesis of (+)- and (−)-Shikimic Acids, (+)- and (−)-4-epi-Shikimic Acids, and (+)- and (−)-Pinitol

Bakthavachalam Ananthan, Wan-Chun Chang, Jhe-Sain Lin, Pin-Hui Li and Tu-Hsin Yan

J. Org. Chem., 2014, 79, 2898
DOI: 10.1021/jo402764v

New lipophilic glycomimetic DC-SIGN ligands: Stereoselective synthesis and SPR-based binding inhibition assays

Sebastiano Di Pietro, Vittorio Bordoni, Dalila Iacopini, Silvia Achilli, Mauro Pineschi, Michel Thépaut, Franck Fieschi, Paolo Crotti and Valeria Di Bussolo

Bioorganic Chemistry, 2021, 107, 104566
DOI: 10.1016/j.bioorg.2020.104566

Production and Synthetic Modifications of Shikimic Acid

Nuno R. Candeias, Benedicta Assoah and Svilen P. Simeonov

Chem. Rev., 2018, 118, 10458
DOI: 10.1021/acs.chemrev.8b00350

2-Azidoethoxy derivatives of 2-aminocyclohexanecarboxylic acids (ACHC): interesting building blocks for the synthesis of cyclic β-peptide conjugates

José J. Reina and Anna Bernardi

Tetrahedron, 2011, 67, 5770
DOI: 10.1016/j.tet.2011.05.131

CellFy: A Cell-Based Fragment Screen against C-Type Lectins

Jessica Schulze, Hannes Baukmann, Robert Wawrzinek, Felix F. Fuchsberger, Edgar Specker, Jonas Aretz, Marc Nazaré and Christoph Rademacher

ACS Chem. Biol., 2018, 13, 3229
DOI: 10.1021/acschembio.8b00875

Molecular Recognition in C‐Type Lectins: The Cases of DC‐SIGN, Langerin, MGL, and L‐Sectin

Pablo Valverde, J. Daniel Martínez, F. Javier Cañada, Ana Ardá and Jesús Jiménez‐Barbero

ChemBioChem, 2020, 21, 2999
DOI: 10.1002/cbic.202000238

Chemoenzymatic Synthesis of Complex N‐Glycans of the Parasite S. mansoni to Examine the Importance of Epitope Presentation on DC‐SIGN recognition

Apoorva D. Srivastava, Luca Unione, Mehman Bunyatov, Ivan A. Gagarinov, Sandra Delgado, Nicola G. A. Abrescia, Ana Ardá and Geert‐Jan Boons

Angewandte Chemie, 2021, 133, 19436
DOI: 10.1002/ange.202105647

Lipid-based mRNA vaccine delivery systems

Patrick Midoux and Chantal Pichon

Expert Review of Vaccines, 2015, 14, 221
DOI: 10.1586/14760584.2015.986104

NMR studies on carbohydrate interactions with DC-SIGN towards a quantitative STD analysis

Cinzia Guzzi, Juan Carlos Muñoz-García, Pedro M. Enriquez-Navas, Javier Rojo, Jesús Angulo and Pedro M. Nieto

Pure and Applied Chemistry, 2013, 85, 1771
DOI: 10.1351/pac-con-12-11-14

Identification of Multiple Druggable Secondary Sites by Fragment Screening against DC‐SIGN

Jonas Aretz, Hannes Baukmann, Elena Shanina, Jonas Hanske, Robert Wawrzinek, Viktor A. Zapol'skii, Peter H. Seeberger, Dieter E. Kaufmann and Christoph Rademacher

Angew Chem Int Ed, 2017, 56, 7292
DOI: 10.1002/anie.201701943

Targeting C-type lectin receptors with multivalent carbohydrate ligands

Bernd Lepenies, Junghoon Lee and Sanjiv Sonkaria

Advanced Drug Delivery Reviews, 2013, 65, 1271
DOI: 10.1016/j.addr.2013.05.007

Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells

Juan J. Garcia-Vallejo, Nathalie Koning, Martino Ambrosini, Hakan Kalay, Ilona Vuist, Ramin Sarrami-Forooshani, Teunis B. H. Geijtenbeek and Yvette van Kooyk

International Immunology, 2013, 25, 221
DOI: 10.1093/intimm/dxs115

Structure of a Glycomimetic Ligand in the Carbohydrate Recognition Domain of C-type Lectin DC-SIGN. Structural Requirements for Selectivity and Ligand Design

Michel Thépaut, Cinzia Guzzi, Ieva Sutkeviciute, Sara Sattin, Renato Ribeiro-Viana, Norbert Varga, Eric Chabrol, Javier Rojo, Anna Bernardi, Jesus Angulo, Pedro M. Nieto and Franck Fieschi

J. Am. Chem. Soc., 2013, 135, 2518
DOI: 10.1021/ja3053305

Non‐Carbohydrate Glycomimetics as Inhibitors of Calcium(II)‐Binding Lectins

Sakonwan Kuhaudomlarp, Eike Siebs, Elena Shanina, Jérémie Topin, Ines Joachim, Priscila da Silva Figueiredo Celestino Gomes, Annabelle Varrot, Didier Rognan, Christoph Rademacher, Anne Imberty and Alexander Titz

Angewandte Chemie, 2021, 133, 8185
DOI: 10.1002/ange.202013217

Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act

Xujun Cao, Anthony F. Cordova and Lingyin Li

Chem. Rev., 2022, 122, 3414
DOI: 10.1021/acs.chemrev.1c00716

Sole Anti-inflammatory Immunomodulators: Innovative Drugs to Prevent and Treat Autoimmune Diseases and Proteopathies

Dante J. Marciani

CCS, 2021, 1, 273
DOI: 10.2174/2210298101666210108110556

The chemistry of the carbon–transition metal double and triple bond: Annual survey covering the year 2010

James W. Herndon

Coordination Chemistry Reviews, 2012, 256, 1281
DOI: 10.1016/j.ccr.2012.02.015

Glycoconjugates and Glycomimetics as Microbial Anti-Adhesives

Sara Sattin and Anna Bernardi

Trends in Biotechnology, 2016, 34, 483
DOI: 10.1016/j.tibtech.2016.01.004

A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus

Norbert Varga, Ieva Sutkeviciute, Renato Ribeiro-Viana, Angela Berzi, Rasika Ramdasi, Anna Daghetti, Gerolamo Vettoretti, Ali Amara, Mario Clerici, Javier Rojo, Franck Fieschi and Anna Bernardi

Biomaterials, 2014, 35, 4175
DOI: 10.1016/j.biomaterials.2014.01.014

Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition

Vanessa Porkolab, Eric Chabrol, Norbert Varga, Stefania Ordanini, Ieva Sutkevičiu̅tė, Michel Thépaut, Maria José García-Jiménez, Eric Girard, Pedro M. Nieto, Anna Bernardi and Franck Fieschi

ACS Chem. Biol., 2018, 13, 600
DOI: 10.1021/acschembio.7b00958

Glycodendritic structures: tools to interact with DC-SIGN

Jose J. Reina and Javier Rojo

Braz. J. Pharm. Sci., 2013, 49, 109
DOI: 10.1590/S1984-82502013000700009

Strategies for the Development of Glycomimetic Drug Candidates

Rachel Hevey

Pharmaceuticals, 2019, 12, 55
DOI: 10.3390/ph12020055